Impact of persistent D-dimer elevation following recovery from COVID-19
- PMID: 34710097
- PMCID: PMC8553152
- DOI: 10.1371/journal.pone.0258351
Impact of persistent D-dimer elevation following recovery from COVID-19
Abstract
Background: Elevated D-dimer is known as predictor for severity of SARS-CoV2-infection. Increased D-dimer is associated with thromboembolic complications, but it is also a direct consequence of the acute lung injury seen in COVID-19 pneumonia.
Objectives: To evaluate the rate of persistent elevated D-dimer and its association with thromboembolic complications and persistent ground glass opacities (GGO) after recovery from COVID-19.
Methods: In this post hoc analysis of a prospective multicenter trial, patients underwent blood sampling, measurement of diffusion capacity, blood gas analysis, and multidetector computed tomography (MDCT) scan following COVID-19. In case of increased D-dimer (>0,5 μg/ml), an additional contrast medium-enhanced CT was performed in absence of contraindications. Results were compared between patients with persistent D-dimer elevation and patients with normal D-dimer level.
Results: 129 patients (median age 48.8 years; range 19-91 years) underwent D-Dimer assessment after a median (IQR) of 94 days (64-130) following COVID-19. D-dimer elevation was found in 15% (19/129) and was significantly more common in patients who had experienced a severe SARS-CoV2 infection that had required hospitalisation compared to patients with mild disease (p = 0.049). Contrast-medium CT (n = 15) revealed an acute pulmonary embolism in one patient and CTEPH in another patient. A significant lower mean pO2 (p = 0.015) and AaDO2 (p = 0.043) were observed in patients with persistent D-Dimer elevation, but the rate of GGO were similar in both patient groups (p = 0.33).
Conclusion: In 15% of the patients recovered from COVID-19, persistent D-dimer elevation was observed after a median of 3 months following COVID-19. These patients had experienced a more severe COVID and still presented more frequently a lower mean pO2 and AaDO2.
Conflict of interest statement
NO authors have competing interests.
Figures
Similar articles
-
Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer.Eur J Radiol. 2020 Nov;132:109336. doi: 10.1016/j.ejrad.2020.109336. Epub 2020 Oct 6. Eur J Radiol. 2020. PMID: 33069986 Free PMC article.
-
Association between D-dimer level and chest CT severity score in patients with SARS-COV-2 pneumonia.Sci Rep. 2021 Jun 2;11(1):11636. doi: 10.1038/s41598-021-91150-1. Sci Rep. 2021. PMID: 34079027 Free PMC article.
-
D-Dimer as a potential biomarker for disease severity in COVID-19.Am J Emerg Med. 2021 Feb;40:55-59. doi: 10.1016/j.ajem.2020.12.023. Epub 2020 Dec 14. Am J Emerg Med. 2021. PMID: 33348224 Free PMC article.
-
D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis.Tuberk Toraks. 2020 Dec;68(4):353-360. doi: 10.5578/tt.70351. Tuberk Toraks. 2020. PMID: 33448732 English.
-
Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression.Front Immunol. 2021 May 7;12:691249. doi: 10.3389/fimmu.2021.691249. eCollection 2021. Front Immunol. 2021. PMID: 34025688 Free PMC article.
Cited by
-
Symptom burden, coagulopathy and heart disease after acute SARS-CoV-2 infection in primary practice.Sci Rep. 2024 Sep 11;14(1):21229. doi: 10.1038/s41598-024-71535-8. Sci Rep. 2024. PMID: 39261512 Free PMC article.
-
The Effect of Antidepressant Treatment on Neurocognitive Functions, Redox and Inflammatory Parameters in the Context of COVID-19.J Clin Med. 2023 Nov 12;12(22):7049. doi: 10.3390/jcm12227049. J Clin Med. 2023. PMID: 38002663 Free PMC article.
-
Elevation of D-dimer levels are associated with early need for mechanical ventilation support in patients with COVID-19.BMC Pulm Med. 2023 Aug 3;23(1):283. doi: 10.1186/s12890-023-02551-z. BMC Pulm Med. 2023. PMID: 37537520 Free PMC article.
-
Correlation between Hepatocyte Growth Factor (HGF) with D-Dimer and Interleukin-6 as Prognostic Markers of Coagulation and Inflammation in Long COVID-19 Survivors.Curr Issues Mol Biol. 2023 Jul 8;45(7):5725-5740. doi: 10.3390/cimb45070361. Curr Issues Mol Biol. 2023. PMID: 37504277 Free PMC article. Review.
-
[Evolución de marcadores de laboratorio en pacientes con detección persistente de SARS-CoV-2.].Rev Esp Salud Publica. 2023 May 22;97:e202305039. Rev Esp Salud Publica. 2023. PMID: 37226982 Free PMC article. Spanish.
References
-
- Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, et al.. Elevated D-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Cardiol Rev. 2020. Nov/Dec;28(6):295–302. doi: 10.1097/CRD.0000000000000330 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous